WASHINGTON – The government should ban the diabetes drug Avandia because of a wide variety of life-threatening risks, including heart and liver damage, a consumer group said Thursday.The consumer group, Public Citizen, filed a petition with the Food and Drug ...Read More
* Label changes for Lilly-Amylin diabetes drug * FDA says reports represent small percentage of patients NEW YORK, Nov 2 (Reuters) - Patients and doctors should beaware of possible kidney function problems with Eli Lilly(LLY.N) and Amylin Pharmaceuticals' (AMLN.O) Byetta diabetesdrug, U.S. ...Read More
Rockville-based Human Genome Sciences Inc. announced on Monday that its experimental Lupus drug has completed its final round of testing at a higher dose and will now be headed to the Food and Drug Administration for approval. The latest round of ...Read More
TRENTON, N.J. (AP) - U.S. regulators have refused to accept drugmaker Merck & Co.'s application for a new, combination cholesterol pill that includes rival Pfizer's Lipitor, the world's top-selling drug. Merck disclosed the rare move by the Food and Drug Administration ...Read More
WHITEHOUSE STATION, N.J. -- U.S. regulators won't accept drugmaker Merck's application for a new combination cholesterol pill that includes rival Pfizer's Lipitor, the world's top-selling drug. Merck & Co. disclosed the rare move by the Food and Drug Administration in a regulatory ...Read More
NEW YORK (Dow Jones)--GTx Inc. (GTXI) shares plummeted to an all-time low Monday after the U.S. Food and Drug Administration didn't approve the company's bone drug and said it wants to see an additional late-stage study on the treatment. The FDA ...Read More
BENLYSTA Successful in Second Pivotal Clinical TrialWASHINGTON--(Business Wire)--Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) today announced positiveresults from BLISS-76, the second of two large-scale phase III clinical trialsof BENLYSTA (belimumab) for treating systemic lupus. A full presentation ofresults from BLISS-52 ...Read More
Royal Oak -- Jaclyn Glover smokes clove cigarettes because they smell better, taste better and make her car smell like flowers. With a federal ban on the sweet-smelling cigarettes taking effect this fall, she went to tobacco stores and stocked ...Read More
A new study raises fresh safety concerns about widely used anemia medicines, finding that the drug Aranesp nearly doubled the risk of stroke in people with diabetes and chronic kidney problems who are not yet sick enough to need dialysis. The ...Read More
WASHINGTON -The Food and Drug Administration has allowed drugs for cancer and other diseases to stay on the market even when follow-up studies showed they didn't extend patients' lives, say congressional investigators. A report due out Monday from the Government Accountability ...Read More
(AP) PORTLAND, Ore. - A food industry group is voluntarily halting promotion of its nutrition labeling program after federal regulators said such systems could mislead consumers, officials with the group said Friday.
Industry leaders launched the "Smart Choices" program in August ...Read More
PORTLAND, Ore. (AP) - The Smart Choices nutrition labeling program, created voluntarily by nine large U.S. manufacturers, is halting after federal regulators said such systems could mislead consumers, officials with the labeling group said Friday.
Industry leaders launched the program this ...Read More
PORTLAND, Ore. (AP) - A food industry group is voluntarily halting promotion of its nutrition labeling program after federal regulators said such systems may be misleading consumers, officials with the group said Friday.
Industry leaders launched the "Smart Choices" program in ...Read More
The Smart Choices nutrition labeling program, created voluntarily by nine large U.S. manufacturers, is halting after federal regulators said such systems could mislead consumers, officials with the labeling group said Friday.
Industry leaders launched the program this year to highlight foods ...Read More
PORTLAND, Ore. -- The Smart Choices nutrition labeling program, created voluntarily by nine large U.S. manufacturers, is being halted after federal regulators said such systems could mislead consumers, officials with the labeling group said Friday.
Industry leaders launched the program this ...Read More
PORTLAND, Ore. ? A food labeling program created by U.S. manufacturers is being voluntarily halted after federal regulators said it could be misleading to consumers. Companies such as Kraft, Kellogg and General Mills worked together to launch the "Smart Choices" program ...Read More
WASHINGTON (Reuters) - A Senate bill that would expand U.S. Food and Drug Administration oversight and give it the power to recall food is a step forward but needs to be stronger, the head of the agency told lawmakers on ...Read More
(Updates with company and analyst comments, other details) NEW YORK (Dow Jones)--Amgen Inc. (AMGN) reported a 24% rise in third-quarter profit - easily beating expectations - driven by cost cuts and lower taxes amid strong sales of most major products. The strong ...Read More
NEW YORK (Dow Jones)--Amgen Inc. (AMGN) reported a 24% rise in third-quarter profits, easily beating expectations, driven by cost cuts and strong sales on most major products. The strong earnings prompted the Thousand Oaks, Calif., drug maker to again raise its ...Read More
Amgen Inc. reported its earnings jumped 24% on higher margins, as third-quarter results beat analysts' expectations. The drug maker again boosted its full-year earnings outlook, this time by 10 cents to between $4.90 and $5.05 a share. The Thousand Oaks, Calif., ...Read More
Amgen Inc.'s (AMGN) third-quarter earnings jumped 24% on higher margins as results beat analysts' expectations. The drug maker again boosted its full-year earnings outlook, this time by a dime to $4.90 to $5.05 a share. It affirmed revenue will likely be ...Read More
